End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
91.8 TWD | -0.43% | -.--% | -19.47% |
Apr. 23 | Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 8.95B 290B |
---|---|---|---|---|---|
Net income 2022 | -314M -10.19B | Net income 2023 | -687M -22.3B | EV / Sales 2022 | - |
Net cash position 2022 | 1.6B 51.9B | Net cash position 2023 | 3.22B 104B | EV / Sales 2023 | - |
P/E ratio 2022 |
-39.8
x | P/E ratio 2023 |
-12.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | -0.43% | ||
1 month | -3.06% | ||
3 months | -15.39% | ||
6 months | -23.18% | ||
Current year | -19.47% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
FOU | Founder | 46 | 16-05-11 |
Wan Shan Chen
DFI | Director of Finance/CFO | 38 | 16-05-31 |
Hung Wei Chen
COO | Chief Operating Officer | 43 | 16-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hsien Hua Huang
BRD | Director/Board Member | - | 18-09-26 |
San Chien Tu
BRD | Director/Board Member | - | 18-09-26 |
Chan Yue Li
BRD | Director/Board Member | 52 | 16-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 91.8 | -0.43% | 127,779 |
24-05-30 | 92.2 | +2.33% | 191,744 |
24-05-29 | 90.1 | -0.66% | 85,980 |
24-05-28 | 90.7 | -0.22% | 123,275 |
24-05-27 | 90.9 | -0.98% | 132,113 |
End-of-day quote Taipei Exchange, May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-19.47% | 222M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 6696 Stock